Saltar al contenido
Merck

Cholic Acid-Peptide Conjugates as Potent Antimicrobials against Interkingdom Polymicrobial Biofilms.

Antimicrobial agents and chemotherapy (2019-08-21)
Siddhi Gupta, Jyoti Thakur, Sanjay Pal, Ragini Gupta, Deepakkumar Mishra, Sandeep Kumar, Kavita Yadav, Amandeep Saini, Prabhu S Yavvari, Madhukar Vedantham, Archana Singh, Aasheesh Srivastava, Rajendra Prasad, Avinash Bajaj
RESUMEN

Interkingdom polymicrobial biofilms formed by Gram-positive Staphylococcus aureus and Candida albicans pose serious threats of chronic systemic infections due to the absence of any common therapeutic target for their elimination. Herein, we present the structure-activity relationship (SAR) of membrane-targeting cholic acid-peptide conjugates (CAPs) against Gram-positive bacterial and fungal strains. Structure-activity investigations validated by mechanistic studies revealed that valine-glycine dipeptide-derived CAP 3 was the most effective broad-spectrum antimicrobial against S. aureus and C. albicans CAP 3 was able to degrade the preformed single-species and polymicrobial biofilms formed by S. aureus and C. albicans, and CAP 3-coated materials prevented the formation of biofilms. Murine wound and catheter infection models further confirmed the equally potent bactericidal and fungicidal effect of CAP 3 against bacterial, fungal, and polymicrobial infections. Taken together, these results demonstrate that CAPs, as potential broad-spectrum antimicrobials, can effectively clear the frequently encountered polymicrobial infections and can be fine-tuned further for future applications.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Ciprofloxacin, ≥98% (HPLC)
Sigma-Aldrich
Kanamycin B sulfate salt, aminoglycoside antibiotic
Sigma-Aldrich
N-Phenyl-1-naphthylamine, reagent grade, 98%
Supelco
Neomycin Sulfate, Pharmaceutical Secondary Standard; Certified Reference Material